BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
978 results:

  • 1. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
    Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
    Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
    Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
    BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Diagnosis of bone marrow involvement in angioimmunoblastic T-cell lymphoma should be based on both [
    Liang X; Yang C; Su M; Zou L
    Curr Med Res Opin; 2024 May; 40(5):803-811. PubMed ID: 38626218
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk of progression of early-stage mycosis fungoides, 10-year experience.
    Ariza Gómez SA; Dubeibe Abril PA; Niebles Sincelejo OE; Reina HSL
    An Bras Dermatol; 2024; 99(3):407-413. PubMed ID: 38395632
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging.
    Stoevesandt D; Ludwig C; Mauz-Körholz C; Körholz D; Hasenclever D; McCarten K; Flerlage JE; Kurch L; Wohlgemuth WA; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlén J; Cepelová M; Klekawka T; Attarbaschi A; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Steglich J
    Pediatr Radiol; 2024 May; 54(5):725-736. PubMed ID: 38296856
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Follicular lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
    Sarro R; Bisig B; Guey B; Missiaglia E; Cairoli A; Omoumi P; Letovanec I; Ferry JA; Hasserjian RP; de Leval L
    Mod Pathol; 2024 Apr; 37(4):100440. PubMed ID: 38290600
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. 1q21+ is associated with poor prognosis in newly diagnosed multiple myeloma patients with extramedullary disease: a retrospective study.
    Gao S; Dong F; Yang P; Chen Y; Wang Y; Wang J; Shi Y; Jing H
    Ann Hematol; 2024 Jun; 103(6):1979-1987. PubMed ID: 38206369
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma].
    Liu SZ; Zong XP; Cai WZ; He HJ; Ma ZX; Li JQ; Li CX; Wu DP
    Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):69-73. PubMed ID: 38178771
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metabolic tumour volume in Hodgkin lymphoma-A comparison between manual and AI-based analysis.
    Sadik M; Barrington SF; Trägårdh E; Saboury B; Nielsen AL; Jakobsen AL; Gongora JLL; Urdaneta JL; Kumar R; Edenbrandt L
    Clin Physiol Funct Imaging; 2024 May; 44(3):220-227. PubMed ID: 38011940
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
    Li J; Wang YC; Lin JY
    Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
    [No Abstract]    [Full Text] [Related]  

  • 11. Chemokine Receptor PET/CT Provides Relevant staging and Management Changes in Marginal Zone lymphoma.
    Duell J; Buck AK; Hartrampf PE; Schlötelburg W; Schneid S; Weich A; Dreher N; Lapa C; Kircher M; Higuchi T; Samnick S; Serfling SE; Raderer M; Rasche L; Einsele H; Topp MS; Kosmala A; Werner RA
    J Nucl Med; 2023 Dec; 64(12):1889-1894. PubMed ID: 37797975
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Efficacy and safety of TBI+rATG-based conditioning regimen for haploidentical allogeneic hematopoietic stem cell transplantation in 11 cases of chemotherapy-resistant advanced peripheral T-cell lymphoma].
    Xu R; Li S; Liu HX; Wei DL; Jiang Y; Wang JJ; Liu SS; Wang C; Zhu J
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):578-581. PubMed ID: 37749039
    [No Abstract]    [Full Text] [Related]  

  • 13. [Efficacy and safety of programmed death-1 inhibitor in the treatment of relapsed/refractory classical Hodgkin's lymphoma].
    Shan DD; Liu HM; Liu W; Huang WY; Lyu R; Deng SH; Yi SH; An G; Xu Y; Sui WW; Wang TY; Fu MW; Zhao YZ; Qiu LG; Zou DH
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):555-560. PubMed ID: 37749034
    [No Abstract]    [Full Text] [Related]  

  • 14. [Efficacy and safety of bendamustine-rituximab combination therapy for newly diagnosed indolent B-cell non-Hodgkin's lymphoma and elderly mantle cell lymphoma: a multi-center prospective phase II clinical trial in China].
    Wang H; He Q; Liu D; Deng XZ; Ma J; Xie LN; Sun ZL; Liu C; Zhao RR; Lu K; Chu XX; Gao N; Wei HC; Sun YH; Zhong YP; Xing LJ; Zhang HY; Zhang H; Xu WW; Li ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):550-554. PubMed ID: 37749033
    [No Abstract]    [Full Text] [Related]  

  • 15. Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group.
    Ferdinandus J; van Heek L; Roth K; Dietlein M; Eich HT; Baues C; Borchmann P; Kobe C
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):490-495. PubMed ID: 37735258
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [
    Peng L; Liao Y; Zhou R; Zhong Y; Jiang H; Wang J; Fu Y; Xue L; Zhang X; Sun M; Feng G; Meng Z; Peng S; He X; Teng G; Gao X; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3723-3734. PubMed ID: 37401938
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical Characteristics and Outcomes of Cancer Cases Among Syrian Refugees From Southern Turkey.
    Kutluk T; Sahin B; Kirazli M; Ahmed F; Aydin S; Yesil Çinkir H; Sezgin G; Bayram I; Ebinç S; Isikdogan A; Sasmaz I; Okan V; Ilhan G; Ören AC; Akbayram S; Harputluoglu H; Ural C; Ayyildiz O; Aktas G; Uçar MA; Güvenç B; Köse D; Acipayam C; Güncan S; Erçolak V; Berber I; Akdeniz A; Akyay A; Üzel VH; Söker M; Sengelen M; Yalçin S; Sullivan R
    JAMA Netw Open; 2023 May; 6(5):e2312903. PubMed ID: 37219908
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Positron emission tomography to detect bone marrow involvement for patients with follicular lymphoma: a systematic review and meta-analysis.
    Zheng Y; Liu J; Si J; Xue Q; Chen D; Nuermaimaiti R; Tian C
    Ann Hematol; 2023 Sep; 102(9):2403-2412. PubMed ID: 37209118
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas.
    Maccioni F; Alfieri G; Assanto GM; Mattone M; Gentiloni Silveri G; Viola F; De Maio A; Frantellizzi V; Di Rocco A; De Vincentis G; Pulsoni A; Martelli M; Catalano C
    Radiol Med; 2023 May; 128(5):556-564. PubMed ID: 37145214
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Enhancing information on stage at diagnosis of cancer in Africa.
    Parkin DM; Liu B; Adoubi I; Makouanzi AS; Masalu N; Mrema C; Ndlovu N; Omonisi A; Traore B; Joko-Fru Y
    Acta Oncol; 2023 Apr; 62(4):335-341. PubMed ID: 37102435
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 49.